AU4121899A - Conjugate consisting of a lectin and a blood coagulation factor - Google Patents

Conjugate consisting of a lectin and a blood coagulation factor

Info

Publication number
AU4121899A
AU4121899A AU41218/99A AU4121899A AU4121899A AU 4121899 A AU4121899 A AU 4121899A AU 41218/99 A AU41218/99 A AU 41218/99A AU 4121899 A AU4121899 A AU 4121899A AU 4121899 A AU4121899 A AU 4121899A
Authority
AU
Australia
Prior art keywords
lectin
blood coagulation
coagulation factor
conjugate consisting
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41218/99A
Inventor
Franz Gabor
Peter Turecek
Michael Wirth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter AG
Original Assignee
Baxter AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter AG filed Critical Baxter AG
Publication of AU4121899A publication Critical patent/AU4121899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU41218/99A 1998-06-10 1999-06-09 Conjugate consisting of a lectin and a blood coagulation factor Abandoned AU4121899A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AT100998 1998-06-10
AT1009/98 1999-04-20
AT70199 1999-04-20
AT701/99 1999-04-20
PCT/AT1999/000150 WO1999064072A1 (en) 1998-06-10 1999-06-09 Conjugate consisting of a lectin and a blood coagulation factor

Publications (1)

Publication Number Publication Date
AU4121899A true AU4121899A (en) 1999-12-30

Family

ID=25593654

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41218/99A Abandoned AU4121899A (en) 1998-06-10 1999-06-09 Conjugate consisting of a lectin and a blood coagulation factor

Country Status (4)

Country Link
EP (1) EP1089762A1 (en)
JP (1) JP2002517472A (en)
AU (1) AU4121899A (en)
WO (1) WO1999064072A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2709073A1 (en) 2007-12-27 2009-07-09 Baxter International Inc. Methods for differentiating plasma-derived protein from recombinant protein in a sample
CA3229988A1 (en) * 2021-10-01 2023-04-06 Dhananjay Sathe Recombinant glycan binding proteins and its use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863726A (en) * 1987-05-29 1989-09-05 Cetus Corporation Combination therapy using immunotoxins with interleukin-2
WO1990009799A1 (en) * 1989-02-23 1990-09-07 Colorado State University Research Foundation GnRH ANALOGS FOR DESTROYING GONADOTROPHS
JPH04187644A (en) * 1990-11-21 1992-07-06 Nippon Seiyaku Kk Therapeutic agent for tumor and its production
US5578706A (en) * 1993-11-04 1996-11-26 Board Of Regents, The University Of Texas Methods and compositions concerning homogenous immunotoxin preparations
GB9724143D0 (en) * 1997-11-14 1998-01-14 Andaris Ltd Pharmaceutical conjugate

Also Published As

Publication number Publication date
JP2002517472A (en) 2002-06-18
EP1089762A1 (en) 2001-04-11
WO1999064072A1 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
AU3790399A (en) Blood set and chamber
AU6257599A (en) Non-invasive blood component analyzer
AU2785399A (en) Preparation of polyindanebisphenols and polymers derived therefrom
AU2886499A (en) Transillumination catheter and method
AU6894500A (en) Optoacoustic monitoring of blood oxygenation
AUPP784398A0 (en) Kidney disease detection and treatment
AU6254498A (en) Polyesteramide, its preparation and surgical devices fabricated therefrom
AU7484298A (en) Fetal cardiac monitoring utilizing umbilical blood flow parameters and heartbeatinformation
AU1464500A (en) Footcare device and method of using same
AU3428099A (en) Tubular and flexible vascular prosthesis
AU4717301A (en) Catheter assembly and method of use
AU6266798A (en) Disposable multi-sampler and fitment
AU8967998A (en) Antibiotic-ligand conjugates and methods of use thereof
AU5517399A (en) Coated medical devices and implants
AU2188700A (en) Intravascular cardiac assist device and method
AU3851799A (en) Lactide-containing polymer and medical material
AU6269799A (en) Adrenoleukodystrophy treatments and drug screening
AU6351199A (en) Pectins and the preparation thereof
AU1321101A (en) Cholesterol lowering and blood lipids lowering composition
AU2030197A (en) 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof
AU4121899A (en) Conjugate consisting of a lectin and a blood coagulation factor
AU3132899A (en) A cannula of changeable length and shape
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU6901000A (en) Bioartificial device for propagation of tissue, preparation and uses thereof
AU3020499A (en) A cannula of changeable length and shape

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase